Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Zen Chu
AddedMar 31, 2024
UpdatedJun 28, 2026
Zen Chu

Zen Chu

Founder, Vector Ventures

Crunchbase

Zen Chu's Career

Vector Ventures
Vector Ventures

Boston, MA, US

Founder
Abridge
Abridge

Pittsburgh, PA, US

Board Member· Board
Apex Neuro
Apex Neuro

Boston, MA, US

Board Member· Board
Feelmore Labs
Feelmore Labs

New York, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Zen Chu's Career

Vector Ventures
Vector Ventures
52010Boston, MA, US
Founder

Similar to Vector Ventures

AlwaysraiseVCAlwaysraiseVCSan Francisco, CA, USAlwaysraiseVCSan Francisco, CA, US

Venture capital powerhouse fueling medical device, biopharma, and digital health startups.

5
MedTech Venture PartnersMedTech Venture PartnersMenlo Park, CA, USMedical Devicesest. 2015MedTech Venture PartnersMenlo Park, CA, US · est. 2015

MTVP: A VC firm specializing in seed and early-stage investments in medical device companies.

7
Viking Maccabee VenturesViking Maccabee VenturesNew York City, NY, USMedical Technologyest. 2018Viking Maccabee VenturesNew York City, NY, US · est. 2018

NYC-based Viking Maccabee Ventures invests in early-stage medical tech firms.

50
Pathway BioventuresPathway BioventuresChicago, IL, USMedical Devices, Therapeuticsest. 2018Pathway BioventuresChicago, IL, US · est. 2018

Pathway Bioventures: A seed-stage life sciences fund investing in innovative biotech for unmet medical needs.

3
Abridge
Abridge
Series E-II$757.5M5752018Pittsburgh, PA, US
Board Member· Board

Recent news

Abridge and Availity collaborate to redefine payer-provider collaboration with real-time prior authorizationAbridge Press Release · 2026
Abridge for Nurses named to TIME's Best Inventions of 2025Abridge Blog · 2025
Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private InvestmentsTechCrunch · 2025

Leadership at Abridge

Shiv RaoShiv RaoCo-Founder
Sandeep KonamSandeep KonamCo-Founder
Apex Neuro
Apex Neuro
Series A$4M302015Boston, MA, US
Board Member· Board

Similar to Apex Neuro

NesosNesosRedwood City, CA, USMedical Devices, Softwareest. 2017NesosRedwood City, CA, US · est. 2017

Nēsos: Pioneering wearable tech & software for neurological disorder treatments.

Series B · $16.5M13
DaVinci WearablesDaVinci WearablesCambridge, MA, USHealth Data, Wearablesest. 2022DaVinci WearablesCambridge, MA, US · est. 2022

Davinci Wearables, a Cambridge-based software company, enhances health and lifestyle through smart undergarments and data analytics.

Pre-Seed · $30k6
Neuro42Neuro42Oakland, CA, USMedical Devicesest. 2020Neuro42Oakland, CA, US · est. 2020

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

Series B · $12.8M26
Epic NeuroEpic NeuroFountain Valley, CA, USMedical Devicesest. 2016Epic NeuroFountain Valley, CA, US · est. 2016

EPIC Neuro: Minimally invasive brain stimulation & EEG recording for stroke recovery.

Seed · $1M2
Feelmore Labs
Feelmore Labs
Series A$24M332016New York, US
Co-Founder

Leadership at Feelmore Labs

Francois KressFrancois KressCo-Founder

Similar to Feelmore Labs

Happy HealthHappy HealthAustin, TX, USWearablesest. 2019Happy HealthAustin, TX, US · est. 2019

Happy Health: Austin-based tech firm specializing in stress and mood wearables.

Series A · $60M35
CogwearCogwearPhiladelphia, PA, USHealth Tech, Wearablesest. 2018CogwearPhiladelphia, PA, US · est. 2018

Cogwear develops advanced wearables, providing cognitive and emotional insights to enhance health and performance.

Angel · $356k3
Apex NeuroApex NeuroBoston, MA, USMedical Wearablesest. 2015Apex NeuroBoston, MA, US · est. 2015

Apex Neuro: A disruptive tech firm innovating personal and medical wearables for daily wellness, backed by renowned VC firms.

Series A · $4M30
Embr LabsEmbr LabsBoston, MA, USWearable Devicesest. 2014Embr LabsBoston, MA, US · est. 2014

MIT-founded thermal wellness tech firm, Embr Wave, offers personal thermostat control at your wrist.

Series D · $50.2M30

Zen Chu's Co-Investors

Esther DysonEsther DysonCo-invested · Abridge Series AAneesh ChopraAneesh ChopraCo-invested · Abridge Series ALucy McQuilkenLucy McQuilkenCo-invested · PillPack Series AAndy PalmerAndy PalmerCo-invested · PillPack Series ALucy McAllisterLucy McAllisterCo-invested · PillPack Series ASridhar IyengarSridhar IyengarCo-invested · PillPack Series AWalter WinshallWalter WinshallCo-invested · PillPack Series AYoshua BengioYoshua BengioCo-invested · Abridge Series A

Zen Chu's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Zen Chu

Shiv KrishnanShiv KrishnanCo-Founder · MatrixMedJustin ZhengJustin ZhengFounder · MatrixStephan ShahinianStephan ShahinianFounder · AktiveBayRon TeitelbaumRon TeitelbaumCo-Founder · QwaqDaniel CohenDaniel CohenCo-Founder & CEO · 3DBioGreg WatersGreg WatersCo-Founder · MatrixSpace